Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.

Blockade of collagen-induced arthritis post-onset by antibody to granulocyte-macrophage colony-stimulating factor (GM-CSF): requirement for GM-CSF in the effector phase of disease.
复制标题

DOI:
10.1186/ar318
复制
发表时间:
2001
期刊:
Arthritis research
影响因子:
--
通讯作者:
Hamilton JA
Hamilton JA
中科院分区:
其他
文献类型:
--
作者:
Cook AD;Braine EL;Campbell IK;Rich MJ;Hamilton JA

文献摘要

参考文献

被引文献

相似文献

越来越多的证据表明,生长因子粒细胞-巨噬细胞集落刺激因子(GM-CSF)在包括关节炎在内的炎症性疾病中发挥了作用。在本研究中,我们观察了抗GM-CSF中和单抗治疗胶原性关节炎(CIA)的有效性。免疫DBA/1小鼠建立CIA模型,在不同时间、不同剂量用中和抗GM-CSF单抗或同型对照单抗进行治疗。在关节炎发作之前,在抗原攻击时,抗GM-CSF单抗治疗在改善随后的疾病方面是有效的。关节炎的调节主要被认为是总体疾病严重程度的降低,无论是每只小鼠受影响的肢体数量还是受影响肢体的临床评分。重要的是,抗GM-CSF单抗治疗改善了现有的疾病,这既被视为减少了最初受影响的肢体的进展数量,也减少了受影响的额外肢体的数量。组织学观察,抗GM-CSF组炎症反应减轻,软骨破坏减轻,肿瘤坏死因子-a、IL-1、IL-1、IL在这些小鼠的关节组织清洗中也减少了。然而,抗GM-CSF单抗治疗对II型胶原的体液免疫和细胞免疫均无影响。这些结果表明,GM-CSF在CIA中的主要作用是介导II型胶原炎症反应的效应期。结果还强调了GM-CSF在CIA炎症和关节炎的持续发展中的重要作用,可能对类风湿性关节炎具有治疗意义。
There is mounting evidence for a role of the growth factor granulocyte-macrophage colony-stimulating factor (GM-CSF) in inflammatory disease, including arthritis. In the present study, we examined the effectiveness of treatment of collagen-induced arthritis (CIA) with a neutralizing mAb to GM-CSF. DBA/1 mice were immunized for the development of CIA and treated at different times, and with different doses, with neutralizing mAb to GM-CSF or isotype control mAb. Anti-GM-CSF mAb treatment prior to the onset of arthritis, at the time of antigen challenge, was effective at ameliorating the ensuing disease. Modulation of arthritis was seen predominantly as a reduction in overall disease severity, both in terms of the number of limbs affected per mouse and the clinical score of affected limbs. Importantly, anti-GM-CSF mAb treatment ameliorated existing disease, seen both as a reduction in the number of initially affected limbs progressing and lower numbers of additional limbs becoming affected. By histology, both inflammation and cartilage destruction were reduced in anti-GM-CSF-treated mice, and the levels of tumor necrosis factor-a and IL-1? were also reduced in joint tissue washouts of these mice. Neither humoral nor cellular immunity to type II collagen, however, was affected by anti-GM-CSF mAb treatment. These results suggest that the major effect of GM-CSF in CIA is on mediating the effector phase of the inflammatory reaction to type II collagen. The results also highlight the essential role of GM-CSF in the ongoing development of inflammation and arthritis in CIA, with possible therapeutic implications for rheumatoid arthritis.
DOI: 10.1006/cyto.1995.0035
发表时间: 1995-04-01
期刊: CYTOKINE
影响因子: 3.8
作者:
BRISSETTE, WH;BAKER, DA;GRIFFITHS, RJ
通讯作者: GRIFFITHS, RJ
DOI: 10.1182/blood.v88.10.3755.bloodjournal88103755
发表时间: 1996-11-15
期刊: BLOOD
影响因子: 20.3
作者:
Metcalf, D;Robb, L;DiRago, L
通讯作者: DiRago, L
DOI: 10.1002/jcp.1041030309
发表时间: 1980-01-01
影响因子: 5.6
作者:
HAMILTON, JA;STANLEY, ER;SHADDUCK, RK
通讯作者: SHADDUCK, RK
慢性炎性关节炎中的细胞因子。 iv。粒细胞/巨噬细胞刺激因子介导的II类MHC抗原对人单核细胞的诱导:类风湿关节炎中的可能作用。
DOI: 10.1084/jem.170.3.865
发表时间: 1989-09-01
影响因子: 15.3
作者:
Alvaro-Gracia, J M;Zvaifler, N J;Firestein, G S
通讯作者: Firestein, G S
DOI: 10.1073/pnas.89.20.9784
发表时间: 1992-10-15
影响因子: 11.1
作者:
WILLIAMS, RO;FELDMANN, M;MAINI, RN
通讯作者: MAINI, RN